Literature DB >> 14688534

Sirolimus myopathy.

Josef Finsterer, Finsterer Josef, Marina Kanzler, Kanzler Marina, Alois Weinberger, Weinberger Alois.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14688534     DOI： 10.1097/01.TP.0000090752.85709.9F

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  4 in total

Review 1.  [Medically induced myopathia].

Authors:  J Finsterer
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

Review 2.  Benefit-risk assessment of sirolimus in renal transplantation.

Authors:  Dirk R J Kuypers
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  Pharmacometrics and delivery of novel nanoformulated PEG-b-poly(epsilon-caprolactone) micelles of rapamycin.

Authors:  Jaime A Yáñez; M Laird Forrest; Yusuke Ohgami; Glen S Kwon; Neal M Davies
Journal:  Cancer Chemother Pharmacol       Date:  2007-03-29       Impact factor: 3.333

4.  Kidney transplantation in m.3243A>G carriers has outcome implications.

Authors:  Josef Finsterer
Journal:  Clin Kidney J       Date:  2020-02-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.